No Detail Found!

Effectiveness of losartan in extracorporeal shock wave lithotripsy (ESWl) induced nephron injury

Author(s)
Liaqat Ali Institute of Kidney Diseases, Hayatabad Medical Complex,Peshawar -,Pakistan
Faiza Hayat Institute of Kidney Diseases, Hayatabad Medical Complex,Peshawar -,Pakistan
Saifullah Khan Institute of Kidney Diseases, Hayatabad Medical Complex,Peshawar -,Pakistan
Sikander Hayat Institute of Kidney Diseases, Hayatabad Medical Complex,Peshawar -,Pakistan
Mehboob Ul Wahab Institute of Kidney Diseases, Hayatabad Medical Complex,Peshawar -,Pakistan
Asiya Hassan Institute of Kidney Diseases, Hayatabad Medical Complex,Peshawar -,Pakistan
Abstract
Objective: To compare losartan and multi-vitamins as antioxidants in decreasing albuminuria in extra corporeal shock wave lithotripsy (ESWL) related renal injury. Material and Methods: This is a randomized control trial done in the Department of Urology “Team C” at Institute of Kidney Diseases (IKD), Hayatabad Medical Complex Peshawar from June 2018 to March 2020. All the patients with 10 to 15 mm renal stones were included. The patients were divided into two groups; Group A of 90 patients (control) were given multivitamins (Zinc, Selenium, Vitamin A & C) two hours before and one tablet every eight hours after ESWL up to one week. Group B of 90 patients were given Tab. losartan 50 mg two hours before ESWL and once daily after ESWL for one week. The on-spot albuminuria was evaluated before ESWL, at 2-4 hours and one week after standard ESWL (3000 shocks). A structured pro forma was used for the data and the analysis of data was done on SPSS. Results: Almost all the demographics like age, gender, laterality, BMI in both the groups were similar, the albuminuria before ESWL in Group A was 13.9 mg/dl and Group B was 14.1 mg/dl. The albuminuria in Group A was 547 mg/dl after 2-4 hours of ESWL and 581.2mg/dl in Group B (P 0.098). In Group A after one week of ESWL the albuminuria was 88.7 mg/dl versus the albuminuria 41.9 mg/dl in Group B (p< 0.001). Conclusion: Losartan (ARB) is superior to the anti oxidants as a kidney protective agent against ESWL related renal injury by remarkably reduced albuminuria.
Publication Details
Page(s) 145-148
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 28, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Complications, Urolithiasis, Kidney Stone, ESWL, Losartan, Lithotripsy
0

Citations

0

Downloads

40

Views